Drug Type Chemical drugs |
Synonyms CLR 2100 ribosomal inhibitor Cellectar Biosciences/Onconova Therapeutics, Phospholipid etherdrug conjugates Cellectar Biosciences/Onconova Therapeutics, CLR 2100 (Cellectar Biosciences/Onconova Therapeutics) |
Target |
Action inhibitors |
Mechanism Ribosomal proteins inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United States | - | |
Solid tumor | Preclinical | United States | - |